IL99428A - Pharmaceutical preparations containing ranitidine bismuth carborsilate - Google Patents

Pharmaceutical preparations containing ranitidine bismuth carborsilate

Info

Publication number
IL99428A
IL99428A IL9942891A IL9942891A IL99428A IL 99428 A IL99428 A IL 99428A IL 9942891 A IL9942891 A IL 9942891A IL 9942891 A IL9942891 A IL 9942891A IL 99428 A IL99428 A IL 99428A
Authority
IL
Israel
Prior art keywords
composition
methyl
ranitidine
bismuth
salt
Prior art date
Application number
IL9942891A
Other languages
English (en)
Hebrew (he)
Other versions
IL99428A0 (en
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL99428A0 publication Critical patent/IL99428A0/xx
Publication of IL99428A publication Critical patent/IL99428A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/245Bismuth; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Saccharide Compounds (AREA)
IL9942891A 1990-09-11 1991-09-06 Pharmaceutical preparations containing ranitidine bismuth carborsilate IL99428A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909019875A GB9019875D0 (en) 1990-09-11 1990-09-11 Pharmaceutical compositions
NO920408A NO179694C (no) 1990-09-11 1992-01-30 Farmasöytiske preparater inneholdende ranitidinderivater
PCT/EP1992/000498 WO1993017679A1 (en) 1990-09-11 1992-03-05 Compositions containing ranitidine/bismuth carboxylates salts

Publications (2)

Publication Number Publication Date
IL99428A0 IL99428A0 (en) 1992-08-18
IL99428A true IL99428A (en) 1996-06-18

Family

ID=47884627

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9942891A IL99428A (en) 1990-09-11 1991-09-06 Pharmaceutical preparations containing ranitidine bismuth carborsilate

Country Status (33)

Country Link
US (1) US5456925A (sv)
EP (1) EP0558779B1 (sv)
JP (1) JPH0692849A (sv)
KR (1) KR100196308B1 (sv)
AT (2) AT405134B (sv)
AU (2) AU640816B2 (sv)
BE (1) BE1005115A5 (sv)
BG (1) BG61931B1 (sv)
CA (1) CA2050970C (sv)
CH (1) CH683068A5 (sv)
CY (1) CY1988A (sv)
DE (2) DE4130061A1 (sv)
DK (1) DK159191A (sv)
ES (1) ES2072647T3 (sv)
FI (1) FI944047A (sv)
FR (1) FR2666508B1 (sv)
GB (2) GB9019875D0 (sv)
HK (1) HK60894A (sv)
HU (1) HU211846A9 (sv)
IE (1) IE65049B1 (sv)
IL (1) IL99428A (sv)
IT (1) IT1249696B (sv)
MX (1) MX9101009A (sv)
NL (1) NL194907C (sv)
NO (1) NO179694C (sv)
NZ (1) NZ239731A (sv)
OA (1) OA10093A (sv)
RO (1) RO112084B1 (sv)
RU (1) RU2108097C1 (sv)
SE (1) SE509694C2 (sv)
SK (1) SK279591B6 (sv)
WO (1) WO1993017679A1 (sv)
ZA (1) ZA917176B (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
ES2130152T3 (es) * 1991-12-06 1999-07-01 Glaxo Group Ltd Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
GB9127150D0 (en) * 1991-12-20 1992-02-19 Smithkline Beecham Plc Novel treatment
DE69620582T2 (de) * 1995-01-26 2002-11-07 Nycomed Imaging As Verwendung von WISMUTVERBINDUNGEN zur Herstellung eines Arzneimittels zur Behandlung von Magenverstimmungen, die durch Helicobacter pylori verursacht werden
GB9501560D0 (en) 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
RU2203048C2 (ru) * 1998-08-18 2003-04-27 Леонидов Николай Борисович Физически устойчивая рентгеноаморфная форма ранитидина гидрохлорида с повышенной противоязвенной активностью и способ ее получения
EP1104673A1 (en) * 1999-11-30 2001-06-06 Bayer Classics A hydrogen carbonate-containing, desintegrating agent-free pharmaceutical composition
KR100412290B1 (ko) * 2001-11-27 2003-12-31 주식회사 동구제약 라니티딘 함유 현탁제 조성물 및 그의 제조방법
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
JP5553830B2 (ja) * 2008-07-21 2014-07-16 アルベマール・コーポレーシヨン 高含量イブプロフェンナトリウム顆粒、その調製、および非発泡性固体剤形を調製する際のその使用
CN115697354A (zh) * 2020-06-01 2023-02-03 香港大学 用于治疗sars-cov-2感染的组合物和方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608257A (en) * 1984-01-03 1986-08-26 Board Of Regents For Oklahoma State University Composition and method for treating heat stress
GB8629781D0 (en) * 1986-12-12 1987-01-21 Glaxo Group Ltd Pharmaceutical compositions
DE3874917T2 (de) * 1987-03-09 1993-03-04 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
DE3710462A1 (de) * 1987-03-30 1988-10-13 Heumann Pharma Gmbh & Co Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes
FR2633181B1 (fr) * 1988-06-24 1992-01-10 Glaxo Lab Sa Composition pharmaceutique a base de ranitidine et son procede de preparation
CH679582A5 (sv) * 1988-07-18 1992-03-13 Glaxo Group Ltd
ES2040307T3 (es) * 1988-10-08 1993-10-16 Dr. R. Pfleger Chemische Fabrik Gmbh Procedimiento para producir un preparado medicamentoso liquido que contiene bismuto.
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
US5013560A (en) * 1989-03-17 1991-05-07 The Procter & Gamble Company Microbially-stable bismuth-containing liquid pharmaceutical suspensions
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
FI944047A0 (sv) 1994-09-02
GB9119284D0 (en) 1991-10-23
FI944047A (sv) 1994-09-02
GB2248185A (en) 1992-04-01
ATE122883T1 (de) 1995-06-15
CA2050970C (en) 2002-11-19
AU1334792A (en) 1993-10-05
AT405134B (de) 1999-05-25
ATA180191A (de) 1998-10-15
HK60894A (en) 1994-07-08
MX9101009A (es) 1992-05-04
SE509694C2 (sv) 1999-02-22
NL194907B (nl) 2003-03-03
SE9102604L (sv) 1992-03-12
HU211846A9 (en) 1995-12-28
WO1993017679A1 (en) 1993-09-16
IE65049B1 (en) 1995-10-04
RU2108097C1 (ru) 1998-04-10
US5456925A (en) 1995-10-10
FR2666508B1 (fr) 1994-02-18
AU640816B2 (en) 1993-09-02
JPH0692849A (ja) 1994-04-05
FR2666508A1 (fr) 1992-03-13
NO179694C (no) 1996-12-04
NL194907C (nl) 2003-07-04
IT1249696B (it) 1995-03-09
ITRM910673A1 (it) 1993-03-10
KR100196308B1 (ko) 1999-06-15
BG99021A (bg) 1995-06-30
AU8375791A (en) 1992-03-19
SK279591B6 (sk) 1999-01-11
DK159191A (da) 1992-03-12
RO112084B1 (ro) 1997-05-30
ITRM910673A0 (it) 1991-09-10
BE1005115A5 (fr) 1993-04-27
ZA917176B (en) 1992-06-24
GB2248185B (en) 1994-02-02
SE9102604D0 (sv) 1991-09-10
DK159191D0 (da) 1991-09-10
DE4130061A1 (de) 1992-03-12
GB9019875D0 (en) 1990-10-24
BG61931B1 (bg) 1998-10-30
NO920408L (no) 1993-08-02
IL99428A0 (en) 1992-08-18
EP0558779B1 (en) 1995-05-24
NL9101533A (nl) 1992-04-01
CA2050970A1 (en) 1992-03-12
NO179694B (no) 1996-08-26
SK106094A3 (en) 1995-02-08
CY1988A (en) 1997-09-05
NZ239731A (en) 1993-10-26
EP0558779A1 (en) 1993-09-08
KR920005984A (ko) 1992-04-27
NO920408D0 (no) 1992-01-30
IE913191A1 (en) 1992-04-22
CH683068A5 (fr) 1994-01-14
ES2072647T3 (es) 1995-07-16
OA10093A (en) 1996-12-18
DE69202696D1 (de) 1995-06-29

Similar Documents

Publication Publication Date Title
JP7216055B2 (ja) 医薬組成物
JP5352474B2 (ja) 口腔内崩壊錠およびその製造方法
US4665081A (en) Solid nifedipine preparations and a process for preparing same
JP4740740B2 (ja) 薬物含有粒子および該粒子を含む固形製剤
AU630536B2 (en) Pimobendan compositions
CA2000763C (en) Dispersable formulation
AU4373300A (en) Flash-melt oral dose formulations
US5456925A (en) Pharmaceutical compositions containing furan derivatives
US5814339A (en) Film coated tablet of paracetamol and domperidone
US3865935A (en) Tableting of erythromycin base
JP2005139085A (ja) 顆粒
JPS60163823A (ja) 経口投与製剤
EP0814772B1 (en) Pectin pharmaceutical compositions
JPWO2007023729A1 (ja) 徐放性製剤
UA79567C2 (en) Orodispersible pharmaceutical composition of antithrombolic compound
HU217587B (hu) Ranitidint és bizmut-karboxilát-komplexet, valamint bázisos sókat tartalmazó gyógyászati készítmények
CZ209794A3 (en) Pharmaceutical preparation

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees